Skip to main content
NCBI home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1985 Feb;94(1):87–95. doi: 10.1017/s0022172400061167

Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine.

R Jennings, T L Smith, A R Mellersh, A Clark, R C Spencer, C W Potter
PMCID: PMC2129390  PMID: 3973383

Abstract

The serum antibody responses and 50% protective levels (PL50) of antibody were determined, using the SRH test, at one and twelve months post-vaccination in a group of student volunteers immunized with one of three dosages of a trivalent surface-antigen influenza virus vaccine, or with placebo. It was found that, for the H3, H1 and B haemagglutinin components present in the vaccine, a dose of 6 micrograms HA elicited high serum antibody responses at one month post-immunization. High mean antibody levels and a high incidence of volunteers with PL50 values of antibody against each of the HA components of the vaccine remained in the volunteer group twelve months later. The results are discussed in relation to the vaccine dosage used and the nature of the population immunized.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Khayatt R., Jennings R., Potter C. W. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg (Lond) 1984 Oct;93(2):301–312. doi: 10.1017/s0022172400064834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brady M. I., Furminger I. G. A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins. J Hyg (Lond) 1976 Oct;77(2):161–172. doi: 10.1017/s002217240002458x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cate T. R., Couch R. B., Parker D., Baxter B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. Rev Infect Dis. 1983 Jul-Aug;5(4):737–747. doi: 10.1093/clinids/5.4.737. [DOI] [PubMed] [Google Scholar]
  4. Clark A., Potter C. W., Jennings R., Nicholl J. P., Langrick A. F., Schild G. C., Wood J. M., Tyrrell D. A. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. J Hyg (Lond) 1983 Jun;90(3):361–370. doi: 10.1017/s0022172400028990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goodeve A. C., Jennings R., Potter C. W. The use of the single radial haemolysis test for assessing antibody response and protective antibody levels in an influenza B vaccine study. J Biol Stand. 1983 Oct;11(4):289–296. doi: 10.1016/s0092-1157(83)80017-1. [DOI] [PubMed] [Google Scholar]
  6. Goodeve A., Potter C. W., Clark A., Jennings R., Schild G. C., Yetts R. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection. J Hyg (Lond) 1983 Feb;90(1):107–115. doi: 10.1017/s0022172400063907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jennings R., Clark A., Oxford J. S., Hockley D. J., Potter C. W. Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers. J Infect Dis. 1978 Nov;138(5):577–586. doi: 10.1093/infdis/138.5.577. [DOI] [PubMed] [Google Scholar]
  8. Jennings R., Potter C. W., Massey P. M., Duerden B. I., Martin J., Bevan A. M. Responses of volunteers to inactivated influenza virus vaccines. J Hyg (Lond) 1981 Feb;86(1):1–16. doi: 10.1017/s0022172400068698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jennings R., Smith T. L., Spencer R. C., Mellersh A. M., Edey D., Fenton P., Potter C. W. Inactivated influenza virus vaccines in man: a comparative study of subunit and split vaccines using two methods for assessment of antibody responses. Vaccine. 1984 Mar;2(1):75–80. doi: 10.1016/s0264-410x(98)90036-6. [DOI] [PubMed] [Google Scholar]
  10. Kunz C., Hofmann H., Moritz A., Bachmayer H., Liehl E. Eine neue Influenza Subunit Vakzine: Hämagglutinations-hemmende Antikörper ein Jahr nach der Impfung. Infection. 1978;6(5):217–220. doi: 10.1007/BF01642312. [DOI] [PubMed] [Google Scholar]
  11. Lerman S. J., Wright P. F., Patil K. D. Antibody decline in children following A/New Jersey/76 influenza virus immunization. J Pediatr. 1980 Feb;96(2):271–274. doi: 10.1016/s0022-3476(80)80823-7. [DOI] [PubMed] [Google Scholar]
  12. Noble G. R., Kaye H. S., O'Brien R. J., Kendal A. P., Bregman D. J., Wright P. F., Amler R. W., Dowdle W. R. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination. Dev Biol Stand. 1977 Jun 1;39:253–260. [PubMed] [Google Scholar]
  13. Oxford J. S., Yetts R., Schild G. C. Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis. J Hyg (Lond) 1982 Apr;88(2):325–333. doi: 10.1017/s0022172400070170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Potter C. W., Clark A., Jennings R., Schild G. C., Wood J. M., McWilliams P. K. Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand. 1980;8(1):35–48. doi: 10.1016/s0092-1157(80)80045-x. [DOI] [PubMed] [Google Scholar]
  15. Potter C. W., Jennings R., Phair J. P., Clarke A., Stuart-Harris C. H. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine. J Infect Dis. 1977 Mar;135(3):423–431. doi: 10.1093/infdis/135.3.423. [DOI] [PubMed] [Google Scholar]
  16. Ruben F. L., Jackson G. G. A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity. J Infect Dis. 1972 Jun;125(6):656–664. doi: 10.1093/infdis/125.6.656. [DOI] [PubMed] [Google Scholar]
  17. Wood J. M., Schild G. C., Newman R. W., Seagroatt V. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand. 1977;5(3):237–247. doi: 10.1016/s0092-1157(77)80008-5. [DOI] [PubMed] [Google Scholar]
  18. Závadová H., Adam E., Vonka V., Domorázková E., Kratochvílová M., Burian V., Davenport F. M. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants. Arch Gesamte Virusforsch. 1972;36(1):53–61. [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES